C5 and breast cancer: To further investigate whether MAPK/p38 is involved in the C5a/C5aR pathway-mediated downregulation of the cell cycle protein p21 in BC, we treated the BC cell line MCF-7 cells with the recombinant C5a and measured the expression of MAPK/p38 and p21.